Abstract
Objective/Purpose While we await outcomes from randomized studies, APBI has seen increasing use as an alternative to whole breast irradiation (WBI) after lumpectomy for early stage breast cancer. Recently, there has been concern generated about excess toxicity associated with brachytherapy APBI. Multi-catheter (MCT) brachytherapy, as the initial APBI method developed, has the longest follow-up and provides a means for looking at late outcomes.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Radiation Oncology*Biology*Physics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
